Larrinaga Embeita, G., Valdivia Palacin, A., Arrieta Aguirre, I., Solano Iturri, J. D., Ugalde Olano, A., Loizaga Iriarte, A., . . . López Fernández de Villaverde, J. I. (2024). The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.
Citación estilo ChicagoLarrinaga Embeita, Gorka, et al. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated With a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. 2024.
Cita MLALarrinaga Embeita, Gorka, et al. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated With a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. 2024.